About
Lauren Troy is A/Head of Department of Respiratory and Sleep Medicine at Royal Prince Alfred Hospital, a Visiting Medical Officer at Chris O’Brien Lifehouse and Clinical Senior Lecturer for University of Sydney. She has been a clinical leader in the RPAH response to the COVID-19 pandemic. She has clinical and research expertise in Interstitial Lung Disease (ILD) and is a key member of the RPAH ILD Multidisciplinary Service. She is the primary interventional pulmonologist at RPAH and Lifehouse, with extensive training in advanced bronchoscopic procedures. Dr Troy was the Principal Investigator of the COLDICE (Cryobiopsy versus Open Lung biopsy for the Diagnosis of ILD alliance) Trial, a first-of-kind Australian investigator initiated multicentre study, with impact on global ILD diagnostic practice.
Lauren Troy has published over peer-reviewed manuscripts, and 1 book chapter. Her original research findings have been published and editorialised in leading Respiratory Medicine journals, including Lancet Respiratory Medicine and American Journal of Respiratory and Critical Care Medicine. She has garnered international recognition as a diagnostician in ILD and is currently sitting on two international guideline committees, including the current American Thoracic Society (ATS)/ European Respiratory Society (ERS) Idiopathic Pulmonary Fibrosis (IPF) Clinical Practice Guidelines (subgroup leader), and the ERS Task Force for Transbronchial lung cryobiopsy in ILD. She is a current member of the Australia and New Zealand Adult Domiciliary Oxygen Guidelines Working Group.